Marzullo G y cols. Mesotelioma peritoneal mulꢁquísꢁco benigno. Rev Argent Cir. 2025;117(1):1-5
5
include cysꢀc lymphangioma of the retroperitoneum,
cysꢀc form of endosalpingiosis, endometriosis,
Mullerian cysts, cysꢀc adenomatoid tumors, and
cysꢀc mesonephric duct remnants. Malignant lesions
mimicking BMPM include serous tumors involving
the peritoneum, ovarian clear cell carcinomas and
malignant mesothelioma. The differenꢀal diagnosis
with malignant mesothelioma is crucial for paꢀents’
■
FIGURE 2
3
,6
prognosis .
Treatment opꢀons range from conservaꢀve
management to complete resecꢀon followed by
hyperthermic intraperitoneal chemotherapy (HIPEC).
However, there is sꢀll no consensus on the standard
of care and follow-up for these paꢀents. Some experts
suggest a conservaꢀve observaꢀon with serial imaging
Intraoperaꢀve image of the laparoscopic approach
2
tests for asymptomaꢀc paꢀents . Surgical treatment
is considered when the disease becomes aggressive;
yet there are no definiꢀve guidelines for determining
observaꢀon or the frequency of imaging tests in
paꢀents who have undergone conservaꢀve treatment.
Surgery consꢀtutes the mainstay of treatment
findings are usually mulꢀfocal cysꢀc lesions in the
peritoneal and pelvic cavity. The definiꢀve diagnosis
is made by histopathological examinaꢀon reporꢀng
mulꢀple cysꢀc structures lined with mesothelial
cells and a fibromuscular stroma. Mesothelial cells
are immunoreacꢀve for calreꢀnin, cytokeraꢀn 5/6,
vimenꢀn, Wilms’ tumor anꢀgen and, in some cases,
they are posiꢀve for estrogen receptors, progesterone
in most cases due to the high overall recurrence rate
(
50-60% aꢄer resecꢀon, with 33% in men and 50%
in women). For this reason, an intensive surveillance
program aꢄer primary resecꢀon is warranted. Some
authors suggest a quarterly CT scan during the first year
2
receptors, or both .
It has been suggested that BMPM development
3
aꢄer resecꢀon and then annually for the next 5 years .
is linked to sex hormone sensiꢀvity because of its high
Although the eꢀology and treatment of BMPM
are controversial, the prognosis is generally favorable.
2
incidence in women of childbearing age . The clinical
presentaꢀon of this condiꢀon is variable and may
Only two cases of malignant transformaꢀon and only
3
include mild to severe abdominal pain, the presence of one case of death have been reported in the literature .
5
a palpable abdominal mass, or pelvic discomfort .
Finally, we consider the paucity of published
The differenꢀal diagnosis of BMPM includes a literature on this condiꢀon an important limitaꢀon.
wide range of benign and malignant lesions presenꢀng However, surgery associated with strict monitoring
as abdominal or pelvic cysꢀc masses. Benign lesions appears to be the safest course of acꢀon.
Referencias bibliográꢂcas /References
1
2
.
.
O'Connor DB, Beddy D, Aremu MA. Benign cystic mesothelioma
of the appendix presenting in a woman: a case report. J Med
Case Rep. 2010;4:394.
peritoneal mesothelioma: literature review and update.
Autops Case Rep. 2020;10(3):e2020159.
4. Soon DS, Shilton H, Andrabi A. Mesothelial inclusion cyst: a
rare occurrence. J Surg Case Rep. 2016;2016(12):rjw213.
5. Momeni M, Pereira E, Grigoryan G, Zakashansky K. Multicystic
benign cystic mesothelioma presenting as a pelvic mass. Case
Rep Obstet Gynecol. 2014;2014:852583.
Rapisarda AMC, Cianci A, Caruso S, Vitale SG, Valenti G,
Piombino E, et al. Benign multicystic mesothelioma and
peritoneal inclusion cysts: are they the same clinical and
A systematic review to find
histopathological entities?
an evidence-based management. Arch Gynecol Obstet.
018;297(6):1353-75.
Chand MT, Edens J, Lin T, Anderson I, Berri R. Benign multicystic
6. Singh A, Chatterjee P, Pai MC, Chacko RT. Multicystic peritoneal
mesothelioma: not always a benign disease. Singapore Med J.
2013 r;54(4):e76-8.
2
3
.